Multiple sclerosis: relation to scrapie and slow infection; ageing and measles

Insights

Multiple Sclerosis (MS) is not caused by scrapie or aging, despite some shared antigens. Research suggests an immunological mechanism, possibly involving linoleic acid and genetic factors, is the likely cause of MS lesions.

Area of Science:

  • Neuroimmunology
  • Infectious Disease Epidemiology

Background:

  • Multiple Sclerosis (MS) etiology remains debated, with previous theories suggesting infectious or aging-related causes.
  • Scrapie-like antigens and their association with aging and MS require further clarification.
  • The role of viral infections, such as measles, in MS pathogenesis is under scrutiny.

Purpose of the Study:

  • To investigate the relationship between Multiple Sclerosis (MS) and scrapie.
  • To explore potential infectious and aging-related etiologies of MS.
  • To identify key immunological factors involved in MS lesion development.

Main Methods:

  • Comparative analysis of MS and scrapie.
  • Assessment of lymphocyte sensitization to scrapie and inhibition by linoleic acid.
  • Review of familial background, genetic markers, HLA studies, and viral antibody titers.

Main Results:

  • No direct relation found between Multiple Sclerosis (MS) and scrapie; evidence for a slow infective cause is weak.
  • Increased sensitization of MS lymphocytes to scrapie is not specific to MS.
  • Specific lymphocyte sensitivity to linoleic acid inhibition is characteristic of MS, unlike scrapie.
  • Measles virus plays a potential role in a subset of childhood-acquired MS cases, but not most.
  • Raised antibodies to non-measles viruses have been observed in MS patients.

Conclusions:

  • An immunological mechanism is the most probable pathway for Multiple Sclerosis (MS) lesion development.
  • Scrapie and aging processes are unlikely primary causes of MS.
  • Further research integrating genetic markers, HLA, and linoleic acid studies is warranted for MS etiology.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...